Amplify Treatments, Testing and Advancements ETF (GERM) Alternatives
Amplify Treatments, Testing and Advancements ETF (GERM) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with GERM. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.
Cheapest Alternatives to GERM
GERM charges 0.68% annually. Among ETFs in the Health & Biotech Equities category, these options have the lowest expense ratios among GERM alternatives.
| Symbol | Name | Expense Ratio | Inception | |
|---|---|---|---|---|
| Fidelity MSCI Health Care Index ETF | 0.08% | Oct 21, 2013 | GERM vs FHLC | |
| State Street Health Care Select Sector SPDR ETF | 0.08% | Dec 16, 1998 | GERM vs XLV | |
| Vanguard Health Care ETF | 0.10% | Jan 26, 2004 | GERM vs VHT | |
| Invesco S&P SmallCap Health Care ETF | 0.29% | Apr 7, 2010 | GERM vs PSCH | |
| SPDR S&P Pharmaceuticals ETF | 0.35% | Jun 19, 2006 | GERM vs XPH |
Best Risk-Adjusted Alternatives to GERM
Among ETFs in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.
| Symbol | Name | Risk / Return Rank | Inception | |
|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 97 | Dec 16, 2014 | GERM vs BBC | |
| ALPS Medical Breakthroughs ETF | 95 | Dec 31, 2014 | GERM vs SBIO | |
| SPDR S&P Biotech ETF | 92 | Feb 6, 2006 | GERM vs XBI | |
| Tema Oncology ETF | 90 | Aug 14, 2023 | GERM vs CANC | |
| F/m Emerald Life Sciences Innovation ETF | 86 | Oct 30, 2024 | GERM vs LFSC |
Top Performing GERM Alternatives (YTD)
GERM alternatives from the Health & Biotech Equities category, sorted by year-to-date return.
| Symbol | Name | YTD Return | Inception | |
|---|---|---|---|---|
| iShares Genomics Immunology and Healthcare ETF Gen... | 10.92% | Jun 11, 2019 | GERM vs IDNA | |
| Virtus LifeSci Biotech Clinical Trials ETF | 7.95% | Dec 16, 2014 | GERM vs BBC | |
| Tema Oncology ETF | 5.69% | Aug 14, 2023 | GERM vs CANC | |
| SPDR S&P Biotech ETF | 4.76% | Feb 6, 2006 | GERM vs XBI | |
| First Trust Nasdaq Pharmaceuticals ETF | 4.48% | Sep 20, 2016 | GERM vs FTXH |
Lowest Volatility Alternatives to GERM
GERM alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.
| Symbol | Name | Volatility 1Y | Inception | |
|---|---|---|---|---|
| Principal Healthcare Innovators Index ETF | 0.00% | Aug 19, 2016 | GERM vs BTEC | |
| Loncar Cancer Immunotherapy ETF | 0.00% | Oct 13, 2015 | GERM vs CNCR | |
| Horizon Kinetics SPAC Active ETF | 8.60% | Jun 29, 2007 | GERM vs SPAQ | |
| Global X Aging Population ETF | 15.94% | May 9, 2016 | GERM vs AGNG | |
| Jpmorgan Healthcare Leaders ETF | 17.04% | Nov 1, 2023 | GERM vs JDOC |
Lowest Drawdown Alternatives to GERM
GERM alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.
| Symbol | Name | Max Drawdown 1Y | Inception | |
|---|---|---|---|---|
| Horizon Kinetics SPAC Active ETF | -5.30% | Jun 29, 2007 | GERM vs SPAQ | |
| Jpmorgan Healthcare Leaders ETF | -9.68% | Nov 1, 2023 | GERM vs JDOC | |
| VanEck Vectors Pharmaceutical ETF | -10.02% | Dec 20, 2011 | GERM vs PPH | |
| Global X Aging Population ETF | -10.16% | May 9, 2016 | GERM vs AGNG | |
| iShares Global Healthcare ETF | -10.35% | Nov 13, 2001 | GERM vs IXJ |
Other ETFs from Amplify
Most popular Amplify ETFs on PortfoliosLab, across asset classes.
Often Compared With GERM
What investors most often compare with GERM, based on PortfoliosLab usage data.
Compare GERM with Any Fund or Stock
Compare GERM with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.